{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:20:52Z","timestamp":1792264852313,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,5,25]]},"DOI":"10.1038\/onc.2016.437","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T18:37:56Z","timestamp":1480358276000},"page":"3059-3066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Blockade of the IL-6 trans-signalling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma"],"prefix":"10.1038","volume":"36","author":[{"given":"A","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Alhayyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Szczepny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D N","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Enriori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ferlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ruwanpura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"BFonc2016437_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90: 1905\u20131911.","journal-title":"Br J Cancer"},{"key":"BFonc2016437_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2016437_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489\u2013495.","journal-title":"Lancet Oncol"},{"key":"BFonc2016437_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/NJH.0b013e31825f3470","volume":"14","author":"C Del Ferraro","year":"2012","unstructured":"Del Ferraro C, Grant M, Koczywas M, Dorr-Uyemura LA . Management of anorexia-cachexia in late stage lung cancer patients. J Hosp Palliat Nurs 2012; 14: 397\u2013402.","journal-title":"J Hosp Palliat Nurs"},{"key":"BFonc2016437_CR5","doi-asserted-by":"publisher","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","volume":"9","author":"K Ando","year":"2014","unstructured":"Ando K, Takahashi F, Kato M, Kaneko N, Doi T, Ohe Y et al. Tocilizumab, a proposed therapy for the cachexia of interleukin6-expressing lung cancer. PLoS One 2014; 9: e102436.","journal-title":"PLoS One"},{"key":"BFonc2016437_CR6","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/bjc.1996.294","volume":"73","author":"HR Scott","year":"1996","unstructured":"Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R . The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 1996; 73: 1560\u20131562.","journal-title":"Br J Cancer"},{"key":"BFonc2016437_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/030089160409000207","volume":"90","author":"N Song\u00fcr","year":"2004","unstructured":"Song\u00fcr N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N . Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 2004; 90: 196\u2013200.","journal-title":"Tumori"},{"key":"BFonc2016437_CR8","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","volume":"13","author":"AJ Staal-van den Brekel","year":"1995","unstructured":"Staal-van den Brekel AJ, Dentener M, Schols AM, Buurman WA, Wouters EF . Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13: 2600\u20132605.","journal-title":"J Clin Oncol"},{"key":"BFonc2016437_CR9","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","volume":"31","author":"K Ando","year":"2013","unstructured":"Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K et al. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol 2013; 31: e69\u2013e72.","journal-title":"J Clin Oncol"},{"key":"BFonc2016437_CR10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","volume":"11","author":"TJ Bayliss","year":"2011","unstructured":"Bayliss TJ, Smith JT, Schuster M, Dragnev KH, Rigas JR . A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther 2011; 11: 1663\u20131668.","journal-title":"Expert Opin Biol Ther"},{"key":"BFonc2016437_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12041-011-0027-4","volume":"90","author":"BH Tan","year":"2011","unstructured":"Tan BH, Ross J, Kaasa S, Skorpen F, Fearon KC . European Palliative Care Research Collaborative. Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review. J Genet 2011; 90: 165\u2013177.","journal-title":"J Genet"},{"key":"BFonc2016437_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/bjc.1993.174","volume":"67","author":"Y Ohe","year":"1993","unstructured":"Ohe Y, Podack ER, Olsen KJ, Miyahara Y, Miura K, Saito H et al. Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice. Br J Cancer 1993; 67: 939\u2013944.","journal-title":"Br J Cancer"},{"key":"BFonc2016437_CR13","doi-asserted-by":"publisher","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","volume":"294","author":"KA Baltgalvis","year":"2008","unstructured":"Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ, Carson JA . Interleukin-6 and cachexia in ApcMin\/+ mice. Am J Physiol Regul Integr Comp Physiol 2008; 294: R393\u2013R401.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFonc2016437_CR14","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1172\/JCI115767","volume":"89","author":"G Strassmann","year":"1992","unstructured":"Strassmann G, Fong M, Kenney JS, Jacob CO . Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681\u20131684.","journal-title":"J Clin Invest"},{"key":"BFonc2016437_CR15","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","volume":"303","author":"A Bonetto","year":"2012","unstructured":"Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L et al. JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 2012; 303: E410\u2013E421.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFonc2016437_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1172\/JCI118398","volume":"97","author":"T Tsujinaka","year":"1996","unstructured":"Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996; 97: 244\u2013249.","journal-title":"J Clin Invest"},{"key":"BFonc2016437_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cytogfr.2012.04.001","volume":"23","author":"C Garbers","year":"2012","unstructured":"Garbers C, Hermanns HM, Schaper F, M\u00fcller-Newen G, Gr\u00f6tzinger J, Rose-John S et al. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 2012; 23: 85\u201397.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2016437_CR18","doi-asserted-by":"publisher","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","volume":"6","author":"A Bonetto","year":"2011","unstructured":"Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, Koniaris LG et al. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 2011; 6: e22538.","journal-title":"PLoS One"},{"key":"BFonc2016437_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1096\/fj.13-240580","volume":"28","author":"MJ Puppa","year":"2014","unstructured":"Puppa MJ, Gao S, Narsale AA, Carson JA . Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia. FASEB J 2014; 28: 998\u20131009.","journal-title":"FASEB J"},{"key":"BFonc2016437_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1189\/jlb.1105674","volume":"80","author":"S Rose-John","year":"2006","unstructured":"Rose-John S, Scheller J, Elson G, Jones SA . Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006; 80: 227\u2013236.","journal-title":"J Leukoc Biol"},{"key":"BFonc2016437_CR21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/0008-5472.CAN-15-2388","volume":"76","author":"GD Brooks","year":"2016","unstructured":"Brooks GD, McLeod L, Alhayyani S, Miller A, Russell PA, Ferlin W et al. IL6 trans-signaling promotes KRAS-driven lung carcinogenesis. Cancer Res 2016; 76: 866\u2013876.","journal-title":"Cancer Res"},{"key":"BFonc2016437_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nm1282","volume":"11","author":"BJ Jenkins","year":"2005","unstructured":"Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 2005; 11: 845\u2013852.","journal-title":"Nat Med"},{"key":"BFonc2016437_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1165\/rcmb.2010-0462OC","volume":"45","author":"SM Ruwanpura","year":"2011","unstructured":"Ruwanpura SM, McLeod L, Miller A, Jones J, Bozinovski S, Vlahos R et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol 2011; 45: 720\u2013730.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFonc2016437_CR24","doi-asserted-by":"publisher","first-page":"L627","DOI":"10.1152\/ajplung.00285.2011","volume":"302","author":"SM Ruwanpura","year":"2012","unstructured":"Ruwanpura SM, McLeod L, Miller A, Jones J, Vlahos R, Ramm G et al. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice. Am J Physiol Lung Cell Mol Physiol 2012; 302: L627\u2013L639.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFonc2016437_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R . Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 2014; 14: 736\u2013746.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2016437_CR26","doi-asserted-by":"publisher","first-page":"26943","DOI":"10.1074\/jbc.M115.682138","volume":"290","author":"M Lacroix","year":"2015","unstructured":"Lacroix M, Rousseau F, Guilhot F, Malinge P, Magistrelli G, Herren S et al. Novel insights into interleukin 6 (IL-6) cis- and trans-signaling pathways by differentially manipulating the assembly of the IL-6 signaling complex. J Biol Chem 2015; 290: 26943\u201326953.","journal-title":"J Biol Chem"},{"key":"BFonc2016437_CR27","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.4049\/jimmunol.1002015","volume":"185","author":"R Lissilaa","year":"2010","unstructured":"Lissilaa R, Buatois V, Magistrelli G, Williams AS, Jones GW, Herren S et al. Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity. J Immunol 2010; 185: 5512\u20135521.","journal-title":"J Immunol"},{"key":"BFonc2016437_CR28","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H","volume":"92","author":"S Ahrendt","year":"2001","unstructured":"Ahrendt S, Decker PA, Alawi EA, Zhu YR, Sanchez-Cespedes M, Yang SC et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 2001; 92: 1525\u20131530.","journal-title":"Cancer"},{"key":"BFonc2016437_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 2016; 531: 47\u201352.","journal-title":"Nature"},{"key":"BFonc2016437_CR30","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"E Jackson","year":"2001","unstructured":"Jackson E, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243\u20133248.","journal-title":"Genes Dev"},{"key":"BFonc2016437_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","volume":"19","author":"M Lesina","year":"2011","unstructured":"Lesina M, Kurkowski M, Ludes K, Rose-John S, Treiber M, Kl\u00f6ppel G et al. Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19: 456\u2013469.","journal-title":"Cancer Cell"},{"key":"BFonc2016437_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jcp.24580","volume":"229","author":"M Gilabert","year":"2014","unstructured":"Gilabert M, Calvo E, Airoldi A, Hamidi T, Moutardier V, Turrini O et al. Pancreatic cancer-induced cachexia is Jak2-dependent in mice. J Cell Physiol 2014; 229: 1437\u20131443.","journal-title":"J Cell Physiol"},{"key":"BFonc2016437_CR33","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/1078-0432.CCR-13-2200","volume":"20","author":"E Angevin","year":"2014","unstructured":"Angevin E, Tabernero J, Elez E, Cohen SJ, Bahleda R, van Laethem JL et al. A phase I\/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res 2014; 20: 2192\u20132120.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016437_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage M, Dooley AL, Jacks T . Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 2009; 4: 1064\u20131072.","journal-title":"Nat Protoc"},{"key":"BFonc2016437_CR35","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/onc.2013.205","volume":"33","author":"CL Kennedy","year":"2013","unstructured":"Kennedy CL, Najdovski M, Tye H, McLeod L, Yu L, Jarnicki A et al. Differential role of MyD88 and Mal\/TIRAP in TLR2-mediated gastric tumourigenesis. Oncogene 2013; 33: 2540\u20132546.","journal-title":"Oncogene"},{"key":"BFonc2016437_CR36","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2012.08.010","volume":"22","author":"H Tye","year":"2012","unstructured":"Tye H, Kennedy C, Najdovska M, McLeod L, McCormack W, Hughes N et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 2012; 22: 466\u2013478.","journal-title":"Cancer Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016437","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:08:45Z","timestamp":1647893325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":36,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5,25]]}},"alternative-id":["BFonc2016437"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.437","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"assertion":[{"value":"11 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}